Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Primo Nutraceuticals Inc BUGVF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis-related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.


GREY:BUGVF - Post by User

Primo Nutraceuticals Inc > Good or bad..
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by EdwardMon Feb 19, 2021 8:44am
96 Views
Post# 32607605

RE:Good or bad..

RE:Good or bad..US markey is a farce, like on what, 1 share volume, lol. where is our covid test kits. No matter which way u cut it, whatever you get re marianna is about 50% less then you shouold get
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities